chr10-52280947-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_006258.4(PRKG1):c.1545+17C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000286 in 1,607,822 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000030 ( 0 hom. )
Consequence
PRKG1
NM_006258.4 intron
NM_006258.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.189
Publications
0 publications found
Genes affected
PRKG1 (HGNC:9414): (protein kinase cGMP-dependent 1) Mammals have three different isoforms of cyclic GMP-dependent protein kinase (Ialpha, Ibeta, and II). These PRKG isoforms act as key mediators of the nitric oxide/cGMP signaling pathway and are important components of many signal transduction processes in diverse cell types. This PRKG1 gene on human chromosome 10 encodes the soluble Ialpha and Ibeta isoforms of PRKG by alternative transcript splicing. A separate gene on human chromosome 4, PRKG2, encodes the membrane-bound PRKG isoform II. The PRKG1 proteins play a central role in regulating cardiovascular and neuronal functions in addition to relaxing smooth muscle tone, preventing platelet aggregation, and modulating cell growth. This gene is most strongly expressed in all types of smooth muscle, platelets, cerebellar Purkinje cells, hippocampal neurons, and the lateral amygdala. Isoforms Ialpha and Ibeta have identical cGMP-binding and catalytic domains but differ in their leucine/isoleucine zipper and autoinhibitory sequences and therefore differ in their dimerization substrates and kinase enzyme activity. [provided by RefSeq, Sep 2011]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 10-52280947-C-T is Benign according to our data. Variant chr10-52280947-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 2145446.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAdExome4 at 44 AD gene.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PRKG1 | NM_006258.4 | c.1545+17C>T | intron_variant | Intron 13 of 17 | ENST00000373980.11 | NP_006249.1 | ||
| PRKG1 | NM_001098512.3 | c.1500+17C>T | intron_variant | Intron 13 of 17 | NP_001091982.1 | |||
| PRKG1 | NM_001374781.1 | c.336+17C>T | intron_variant | Intron 9 of 13 | NP_001361710.1 | |||
| PRKG1 | XM_017016413.2 | c.1242+17C>T | intron_variant | Intron 13 of 17 | XP_016871902.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151748Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2
AN:
151748
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000566 AC: 14AN: 247390 AF XY: 0.0000823 show subpopulations
GnomAD2 exomes
AF:
AC:
14
AN:
247390
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000302 AC: 44AN: 1456074Hom.: 0 Cov.: 31 AF XY: 0.0000414 AC XY: 30AN XY: 724154 show subpopulations
GnomAD4 exome
AF:
AC:
44
AN:
1456074
Hom.:
Cov.:
31
AF XY:
AC XY:
30
AN XY:
724154
show subpopulations
African (AFR)
AF:
AC:
0
AN:
33240
American (AMR)
AF:
AC:
0
AN:
44114
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
25976
East Asian (EAS)
AF:
AC:
0
AN:
39584
South Asian (SAS)
AF:
AC:
31
AN:
85438
European-Finnish (FIN)
AF:
AC:
1
AN:
53346
Middle Eastern (MID)
AF:
AC:
4
AN:
5750
European-Non Finnish (NFE)
AF:
AC:
6
AN:
1108434
Other (OTH)
AF:
AC:
2
AN:
60192
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151748Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74054 show subpopulations
GnomAD4 genome
AF:
AC:
2
AN:
151748
Hom.:
Cov.:
32
AF XY:
AC XY:
1
AN XY:
74054
show subpopulations
African (AFR)
AF:
AC:
0
AN:
41322
American (AMR)
AF:
AC:
0
AN:
15150
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3464
East Asian (EAS)
AF:
AC:
0
AN:
5190
South Asian (SAS)
AF:
AC:
1
AN:
4812
European-Finnish (FIN)
AF:
AC:
1
AN:
10530
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
67972
Other (OTH)
AF:
AC:
0
AN:
2080
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.600
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Aortic aneurysm, familial thoracic 8 Benign:1
Jul 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.